Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Annals of the New York Academy of Sciences|July 23, 2005
Advanced glycation end products in diabetes-associated atherosclerosis and renal disease: interventional studiesKarin A Jandeleit-Dahm, Markus Lassila, Terri J Allen
Current Diabetes Reviews|April 18, 2018
SGLT-2 Inhibition: Novel Therapeutics for Reno-and Cardioprotection in Diabetes MellitusAngus Gill, Stephen P Gray, Karin A Jandeleit-Dahm, et al.
Atherosclerosis|January 12, 2007
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouseAnna C Calkin, Terri J Allen, Markus Lassila, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 28, 2004
Imatinib attenuates diabetes-associated atherosclerosisMarkus Lassila, Terri J Allen, Zemin Cao, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2006
PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouseAnna C Calkin, Sara Giunti, Karin A Jandeleit-Dahm, et al.
Circulation|March 17, 2004
Irbesartan but not amlodipine suppresses diabetes-associated atherosclerosisRiccardo Candido, Terri J Allen, Markus Lassila, et al.
Clinical Science (London, England : 1979)|May 1, 2015
Are reactive oxygen species still the basis for diabetic complications?Elyse Di Marco, Jay C Jha, Arpeeta Sharma, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.
American Journal of Physiology. Renal Physiology|June 18, 2010
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouseSara Giunti, Anna C Calkin, Josephine M Forbes, et al.
Free Radical Biology & Medicine|March 5, 2013
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in miceKarina Huynh, Helen Kiriazis, Xiao-Jun Du, et al.
Pageof 3